Impact of Jollab on Blood Parameters in Patients with Breast Cancer Undergoing Chemotherapy: A Pilot Randomized Controlled Trial

  • Bahareh Ahadi 1. School of Medicine, Semnan University of Medical Sciences, Semnan, Iran 2. Department of Traditional Medicine, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Mehdi Pasalar 3. Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
  • Hamid Reza Mirzaei 4. Cancer Research Center, Shohadae Tajrish Hospital, Department of Radiation Oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Reyhaneh Gharehgozlou 4. Cancer Research Center, Shohadae Tajrish Hospital, Department of Radiation Oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Ali Tavakoli 3. Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
  • Ghazaleh Heydarirad Ahadi 2. Department of Traditional Medicine, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran 5. Traditional Medicine and Materia Medica Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Keywords: Jollab; Breast Cancer; Chemotherapy; Honey; Bone Marrow Suppression; Persian Medicine

Abstract

Background: In cancer patients, a prominent side effect of chemotherapy drugs is bone marrow suppression, which leads to decreased blood cell production. Herbal remedies and natural substances such as honey may fulfill a role in relieving this complication. The present study aimed to determine the efficiency of Jollab (a honey-based syrup) in the prevention of pancytopenia in female patients with breast cancer undergoing chemotherapy. Materials and Methods: In a pilot double-blinded, randomized, placebo-controlled clinical trial, 70 patients were examined in terms of leukocyte count, platelet count, and hemoglobin level at the Shohaday-e Tajrish Cancer Clinic (Tehran, Iran) in 2020. The intervention group consumed 10 ml of Jollab syrup three times a day for four weeks, while the control group took a placebo with the same prescription. The independent sample t-test and chi-squared test were used for data analysis in this trial. Results: Our data revealed that the total number of leukocytes, hemoglobin levels, and platelet counts have no significant differences between the two groups at the end of the study, but significant changes were discovered for hemoglobin and platelet levels in intragroup analysis for both intervention and placebo groups. Conclusion: Although the use of Jollab was not found to be effective in augmenting the levels of blood cell parameters in women with breast cancer undergoing chemotherapy, future studies of higher quality may demonstrate its supportive role provided the present limitations are addressed. [GMJ.2021;10:e1972]

References

Nurgalieva Z, Liu C-C, Du XL. Chemotherapy use and risk of bone marrow suppression in a large population-based cohort of older women with breast and ovarian cancer. Med Oncol 2011; 28(3): 716-25.

https://doi.org/10.1007/s12032-010-9512-5

PMid:20361359

Zidan J, Shetver L, Gershuny A, Abzah A, Tamam S, Stein M, et al. Prevention of chemotherapy-induced neutropenia by special honey intake. Med Oncol. 2006; 23(4): 549-52.

https://doi.org/10.1385/MO:23:4:549

PMid:31921435

Krishnakumar GS, Mahendiran B, Gopalakrishnan S, Muthusamy S, Malarkodi Elangovan S. Honey based treatment strategies for infected wounds and burns: A systematic review of recent pre-clinical research. Wound Med. 2020; 30: 100188.

https://doi.org/10.1016/j.wndm.2020.100188

Abdulrhman MA, Hamed AA, Mohamed SA, Hassanen NA. Effect of honey on febrile neutropenia in children with acute lymphoblastic leukemia: A randomized crossover open-labeled study. Complement Ther Med. 2016; 25: 98-103.

https://doi.org/10.1016/j.ctim.2016.01.009

PMid:27062956

Singh M, Chourasia H, Agarwal M, Malhotra A, Sharma M, Sharma D, et al. Honey as complementary medicine:-a review. Int Pharma Bio Sci. 2012; 3(2).

Sadr S, Kaveh S, Choopani R, Bayat H, Mosaddegh M. Efficacy and Safety of Iranian Poly Herbal Formulation (Compound Honey Syrup) in Pediatric Patients with Mild to Moderate Asthma: A Randomized Clinical Trial. Galen Med J. 2017; 6(4): 291-301.

https://doi.org/10.5812/pedinfect.36431

Pasalar M, Choopani R, Mosaddegh M, Kamalinejad M, Mohagheghzadeh A, Fattahi MR, et al. Efficacy of jollab in the treatment of depression in dyspeptic patients: a randomized double-blind controlled trial. J Evid Based Complementary Altern Med. 2015; 20(2): 104-8.

https://doi.org/10.1177/2156587214563542

PMid:25587004

Pasalar M, Choopani R, Mosaddegh M, Kamalinejad M, Mohagheghzadeh A, Fattahi MR, et al. Efficacy and safety of jollab to treat functional dyspepsia: a randomized placebo-controlled clinical trial. Explore (NY). 2015; 11(3): 199-207.

https://doi.org/10.1016/j.explore.2015.02.007

PMid:25777290

Evans JD, Spivak M. Socialized medicine: individual and communal disease barriers in honey bees. J Invertebr Pathol 2010; 103(Suppl): S62-72.

https://doi.org/10.1016/j.jip.2009.06.019

PMid:19909975

Yaghoubi M, Gh G, Satari R. Antimicrobial activity of Iranian propolis and its chemical composition. Daru. 2007; 15(1): 45-8.

Paramasivan S, Drilling AJ, Jardeleza C, Jervis-Bardy J, Vreugde S, Wormald PJ. Methylglyoxal-augmented manuka honey as a topical anti-Staphylococcus aureus biofilm agent: safety and efficacy in an in vivo model. Int Forum Allergy Rhinol. 2014; 4(3): 187-95.

https://doi.org/10.1002/alr.21264

PMid:24415444

Afrin S, Haneefa SM, Fernandez-Cabezudo MJ, Giampieri F, Al-Ramadi BK, Battino M. Therapeutic and preventive properties of honey and its bioactive compounds in cancer: an evidence-based review. Nutr Res Rev. 2020: 33(1): 50-76.

https://doi.org/10.1017/S0954422419000192

PMid:31791437

Norouzian R, Ghafari S, Heydarirad G, Fahimi S. Development of a honey based tonic syrup for cancer-related fatigue. Res J Pharmacogn 2017; 4(Suppl): 60.

Afsari Sardari F, Mosleh G, Azadi A, Mohagheghzadeh A, Badr P. Traditional and Recent Evidence on Five Phytopharmaceuticals from Rosa damascena Herrm. Res J Pharma. 2019; 6(3): 77-84.

Sina HA. Al-Qanun fi al-Tibb [The Canon of Medicine]. Beirut, Lebonan: Alaalami Library; 2005.

Jorjani SE. Zakhireye Kharazm Shahi (Treasure of Kharazm Shah) Tehran: Iranian Medical Academy; 2001.

Arzani MA. Mofareh Al-Gholub. Lahoor: salim lahoor; 1915.

Bhandari PR. Crocus sativus L. (saffron) for cancer chemoprevention: A mini review. J Tradit Complement Med. 2015; 5(2): 81-7.

https://doi.org/10.1016/j.jtcme.2014.10.009

PMid:26151016 PMCid:PMC4488115

Shah ZA, Mir R, Matoo JM, Dar MA, Beigh M. Medicinal importance of saffron: A review. J Pharma Phytochem. 2017; 6(5): 2475-8.

Moazen-Zadeh E, Abbasi SH, Safi-Aghdam H, Shahmansouri N, Arjmandi-Beglar A, Hajhosseinn Talasaz A, et al. Effects of Saffron on Cognition, Anxiety, and Depression in Patients Undergoing Coronary Artery Bypass Grafting: A Randomized Double-Blind Placebo-Controlled Trial. J Altern Complement Med. 2018; 24(4): 361-8.

https://doi.org/10.1089/acm.2017.0173

PMid:29185780

Boskabady MH, Shafei MN, Saberi Z, Amini S. Pharmacological effects of rosa damascena. Iran J Basic Med Sci. 2011; 14(4): 295-307.

Mahboubi M. Rosa damascena as holy ancient herb with novel applications. J Tradit Complement Med. 2016; 6(1): 10-6.

https://doi.org/10.1016/j.jtcme.2015.09.005

PMid:26870673 PMCid:PMC4737971

Aghili Shirazi MH. Moalejat-e Aghili (Persian). Tehran: Institute of Meical History, Islamic Medicine and Complementary Medicine; Iran Medical University; 2008.

Aghili Shirazi MH. Makhzan-al-advia (Persian). Tehran: Tehran University of Medical Sciences; 2009.

Published
2021-02-04
How to Cite
Ahadi, B., Pasalar, M., Mirzaei, H. R., Gharehgozlou, R., Tavakoli, A., & Ahadi, G. H. (2021). Impact of Jollab on Blood Parameters in Patients with Breast Cancer Undergoing Chemotherapy: A Pilot Randomized Controlled Trial. Galen Medical Journal, 10, e1972. https://doi.org/10.31661/gmj.v10i0.1972